Nanocharacterization is providing a comprehensive understanding of materials at the nanoscale. In this context, it involves the analysis and evaluation of pharmaceutical formulations, drug delivery systems, and biomaterials at dimensions ranging from 1 to 100 nanometers. The ability to scrutinize materials at such a minuscule scale allows for a deeper insight into their physicochemical properties, structural features, and interactions, which are critical for optimizing drug performance and ensuring therapeutic efficacy.
Techniques such as atomic force microscopy, transmission electron microscopy, and dynamic light scattering are employed for nanocharacterization, enabling researchers to explore parameters like particle size, shape, surface charge, and drug release kinetics. This meticulous analysis aids in the design and development of nanoscale drug delivery systems, facilitating targeted and controlled release of pharmaceutical agents. Moreover, nanocharacterization contributes to the assessment of biocompatibility, stability, and safety of nanopharmaceuticals, fostering advancements in precision medicine and personalized healthcare. As the pharmaceutical industry continues to harness the potential of nanotechnology, nanocharacterization emerges as an indispensable tool for ensuring the quality, safety, and efficacy of nanomedicines.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico